Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-548 in painful lumbosacral radiculopathy
NCT06176196Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Dec 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suzetrigine in lumbosacral radiculopathy, sponsored by Vertex Pharmaceuticals. Started Dec 2023; status: completed.
02
Drugs
suzetrigine
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT06176196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06176196.